Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 13, Issue 1, Pages 11-15
http://dx.doi.org/10.1080/17402520600557867

Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis

1Department of Hepatology, National Liver Institute, Minufiya University, Minufiya, Egypt
2Division of Internal Medicine, San Paolo School of Medicine, University of Milan, Milan, Italy
3Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, California, USA
4Clinical Pathology Division, National Liver Institute, Minufiya University, Minufiya, Egypt
5Molecular and Cellular Biology Department, Genetic Engineering and Biotechnology Research Institute, Minufiya University, Sadat City, Minufiya, Egypt

Copyright © 2006 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Gamal Badra, Imam Waked, Carlo Selmi, Saleh M. Saleh, Ahmed El-Shaarawy, and Mahmoud Lotfy, “Serum Islet Cell Autoantibodies During Interferon α Treatment in Patients With HCV-Genotype 4 Chronic Hepatitis ,” Clinical and Developmental Immunology, vol. 13, no. 1, pp. 11-15, 2006. https://doi.org/10.1080/17402520600557867.